AXL and neoplasm: We also showed that higher expression of AXL was significantly associated with poor prognosis of patients with TNBC and that a humanized anti-AXL monoclonal antibody could inhibit oncogenic phenotypes in vitro and reduce tumor formation in xenograft mouse models [11].